Skip to content

MPIP: Overcoming barriers to open access for industry

MPIP open access.jpg

The pharmaceutical industry faces barriers to the ‘true’ open access publication of industry-funded research, with journals often applying different access and reuse conditions to such work. Now, as part of its continued drive to support transparency in publishing, Medical Publishing Insights & Practice (MPIP) aims to help authors overcome this issue, with the launch of a bespoke Open Access Journal Tool for Industry (OA-JTI).

The OA-JTI enables users to quickly locate journals offering open access publishing options for industry-sponsored research. Users can search by therapeutic area, publisher, copyright licence, and whether the publisher offers ‘gold’ open access for industry. In a recent blog post, MPIP outline how the tool forms part of a wider strategy to support increased industry adoption of open access by addressing two key issues:

  1. A general lack of understanding of what open access is, why it is important, and how it works
  2. A lack of easily accessible information on open access options available for publication of industry-funded research

As pharmaceutical companies are urged to do more to advocate open access, MPIP hope that — in combination with the recently published Open Access Reference Site and Quick Reference Guide — the OA-JTI will prove to be a useful resource for authors and industry alike.


Summary by Marie Chivers, PhD.

Marie Chivers PhD is a pharmacist and a medical/healthcare writer. Marie can be contacted at


With thanks to our sponsors, Aspire Scientific Ltd and NetworkPharma Ltd

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Leave a Reply

%d bloggers like this: